- Home
- GNFT vs REAL Comparison
GNFT vs REAL Comparison
Compare GNFT & REAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- REAL
- Stock Information
- Founded
- GNFT 1999
- REAL 2011
- Country
- GNFT France
- REAL United States
- Employees
- GNFT N/A
- REAL N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- REAL Other Specialty Stores
- Sector
- GNFT Health Care
- REAL Consumer Discretionary
- Exchange
- GNFT Nasdaq
- REAL Nasdaq
- Market Cap
- GNFT 190.6M
- REAL 982.8M
- IPO Year
- GNFT 2019
- REAL 2019
- Fundamental
- Price
- GNFT $3.67
- REAL $9.33
- Analyst Decision
- GNFT Strong Buy
- REAL Buy
- Analyst Count
- GNFT 1
- REAL 6
- Target Price
- GNFT $13.00
- REAL $7.04
- AVG Volume (30 Days)
- GNFT 8.9K
- REAL 3.8M
- Earning Date
- GNFT 09-19-2024
- REAL 11-04-2024
- Dividend Yield
- GNFT N/A
- REAL N/A
- EPS Growth
- GNFT N/A
- REAL N/A
- EPS
- GNFT 0.47
- REAL N/A
- Revenue
- GNFT $86,225,222.00
- REAL $579,862,000.00
- Revenue This Year
- GNFT $155.44
- REAL $11.26
- Revenue Next Year
- GNFT N/A
- REAL $8.81
- P/E Ratio
- GNFT $7.55
- REAL N/A
- Revenue Growth
- GNFT 175.45
- REAL 2.52
- 52 Week Low
- GNFT $3.31
- REAL $1.52
- 52 Week High
- GNFT $6.42
- REAL $9.78
- Technical
- Relative Strength Index (RSI)
- GNFT 30.71
- REAL 73.17
- Support Level
- GNFT $3.63
- REAL $8.54
- Resistance Level
- GNFT $3.93
- REAL $9.73
- Average True Range (ATR)
- GNFT 0.13
- REAL 0.73
- MACD
- GNFT 0.03
- REAL -0.00
- Stochastic Oscillator
- GNFT 9.93
- REAL 88.10
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the us, generating $1.7 billion in 2023 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 34% of net merchandise value, which excludes returns, cancellations, and first-party sales.